(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH), a medical technology company, Tuesday announced that it expects to repurchase up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.
"All repurchases are expected to be made under the company's existing $1.5 billion share repurchase authorization, which was approved by the Zimmer Biomet Board of Directors and announced in February 2026.", the med-tech company said on a statement.
In pre-market activity, ZBH shares were trading at $80.28, up 0.87% on the New York Stock Exchange.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
